Hongxin Fu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hongxin Fu has a total of 70 co-authors. Here are the top co-authors by number of shared publications:
- Jufang Wang
South China University of Technology
29 shared publications Xiaolong Guo
Guangdong Engineering Research Center of Low-Carbon Synthetic Biotechnology, School of Biology and Biological Engineering
11 shared publicationsJun Feng
School of Biology and Biological Engineering
7 shared publicationsXin Li
Guangdong Engineering Research Center of Low-Carbon Synthetic Biotechnology, School of Biology and Biological Engineering
5 shared publicationsChunyun Qu
Zhongkai Univ Agr & Engn, Coll Light Ind & Food Sci, Guangdong Prov Key Lab Sci & Technol Lingnan Speci, Guangzhou 510225, Peoples R China
4 shared publicationsJiale Cheng
4 shared publications
Latest Publications
- 9 November 2026
- Published by American Chemical Society (ACS) in ACS Synthetic Biology
Stepwise Optimization and Transcription Factor Engineering for Efficient Ectoine Production in Escherichia coli
Ectoine, a high-value compatible solute, is widely used in cosmetics, biopharmaceuticals, and the pharmaceutical industry. Although non-halophilic chassis such as Escherichia coli are preferred for industrial ectoine production, unclear metabolic distributions and physiological constraints have limited titers and productivity. Here, we report a systematic metabolic engineering strategy for high-performance ectoine biosynthesis in E. coli. Introduction of the ectoine gene cluster from Halomonas elongata, coupled with enhanced flux from phosphoenolpyruvate to l-aspartate-β-semialdehyde, established de novo ectoine production. Combinatorial optimization for promoters and expression of an EctBE407D variant collectively increased the ectoine titer by 353% in strain ECT08. Furthermore, the supply of synthetic precursors l-glutamate and oxaloacetic acid was enhanced, elevating the bioproduct to 9.09 g/L in strain ECT18, coupled with a deliberate downregulation of the TCA cycle flux. Transcriptional regulator screening further identified Lrp as a growth-coupled engineering target, whose manipulation enhanced both titer and biomass by 19.83% and 28.62%, respectively. Importantly, metabolic profiles indicated that the Lrp supervised a multi-node regulatory program that alleviated carbon supply, precursor conversion, nitrogen donor availability, and energy efficiency. In fed-batch fermentation, the final strain ECT31 was cultivated in a 7 L bioreactor and induced at 10 h, producing 81.39 g/L ectoine with a yield of 0.31 g/g and a productivity of 0.75 g/L/h. These systematic strategies establish a robust paradigm for the efficient microbial production of aspartate-derived compounds.
- 9 November 2026
- Published by American Chemical Society (ACS) in ACS Synthetic Biology
Stepwise Optimization and Transcription Factor Engineering for Efficient Ectoine Production in Escherichia coli
Ectoine, a high-value compatible solute, is widely used in cosmetics, biopharmaceuticals, and the pharmaceutical industry. Although non-halophilic chassis such as Escherichia coli are preferred for industrial ectoine production, unclear metabolic distributions and physiological constraints have limited titers and productivity. Here, we report a systematic metabolic engineering strategy for high-performance ectoine biosynthesis in E. coli. Introduction of the ectoine gene cluster from Halomonas elongata, coupled with enhanced flux from phosphoenolpyruvate to l-aspartate-β-semialdehyde, established de novo ectoine production. Combinatorial optimization for promoters and expression of an EctBE407D variant collectively increased the ectoine titer by 353% in strain ECT08. Furthermore, the supply of synthetic precursors l-glutamate and oxaloacetic acid was enhanced, elevating the bioproduct to 9.09 g/L in strain ECT18, coupled with a deliberate downregulation of the TCA cycle flux. Transcriptional regulator screening further identified Lrp as a growth-coupled engineering target, whose manipulation enhanced both titer and biomass by 19.83% and 28.62%, respectively. Importantly, metabolic profiles indicated that the Lrp supervised a multi-node regulatory program that alleviated carbon supply, precursor conversion, nitrogen donor availability, and energy efficiency. In fed-batch fermentation, the final strain ECT31 was cultivated in a 7 L bioreactor and induced at 10 h, producing 81.39 g/L ectoine with a yield of 0.31 g/g and a productivity of 0.75 g/L/h. These systematic strategies establish a robust paradigm for the efficient microbial production of aspartate-derived compounds.
- 27 June 2026
- Published by American Chemical Society (ACS) in ACS Sustainable Chemistry & Engineering
- Vol. 14 (28) , 12833-12841
Sustainable Biosynthesis of Butyl Acetate From Glucose: Metabolic Engineering and Process Optimization
Butyl acetate, a valuable industrial chemical, is traditionally produced via energy-intensive processes. In this study, we engineered Clostridium tyrobutyricum for the efficient de novo biosynthesis of butyl acetate from glucose. By introducing a heterologous pathway combining adhE1 and ATF1 and systematically rewiring the central carbon metabolism, we achieved high-level butyl acetate production. A key metabolic engineering insight was that eliminating cryptic chloramphenicol acetyltransferase activity prevented unintended substrate competition, while the overexpression of the ctfAB-adc cluster to reassimilate acetate expanded the acetyl-CoA pool. Through the integration of targeted metabolic engineering and optimized fermentation strategies, a final butyl acetate titer of 43.27 g/L was achieved in a 5 L bioreactor, representing the highest level reported to date, with a yield of 0.20 mol/mol glucose and >98% selectivity. This work not only demonstrates the potential of C. tyrobutyricum as an efficient cell factory for ester synthesis but also establishes a versatile metabolic engineering framework applicable to the sustainable production of a broad range of ester compounds.
- 27 June 2026
- Published by American Chemical Society (ACS) in ACS Sustainable Chemistry & Engineering
- Vol. 14 (28) , 12833-12841
Sustainable Biosynthesis of Butyl Acetate From Glucose: Metabolic Engineering and Process Optimization
Butyl acetate, a valuable industrial chemical, is traditionally produced via energy-intensive processes. In this study, we engineered Clostridium tyrobutyricum for the efficient de novo biosynthesis of butyl acetate from glucose. By introducing a heterologous pathway combining adhE1 and ATF1 and systematically rewiring the central carbon metabolism, we achieved high-level butyl acetate production. A key metabolic engineering insight was that eliminating cryptic chloramphenicol acetyltransferase activity prevented unintended substrate competition, while the overexpression of the ctfAB-adc cluster to reassimilate acetate expanded the acetyl-CoA pool. Through the integration of targeted metabolic engineering and optimized fermentation strategies, a final butyl acetate titer of 43.27 g/L was achieved in a 5 L bioreactor, representing the highest level reported to date, with a yield of 0.20 mol/mol glucose and >98% selectivity. This work not only demonstrates the potential of C. tyrobutyricum as an efficient cell factory for ester synthesis but also establishes a versatile metabolic engineering framework applicable to the sustainable production of a broad range of ester compounds.
- Open Access
Design and Characterization of Recombinant and Chimeric BoNT/A Neurotoxins with Receptor-Binding Domain Grafting
Botulinum neurotoxins (BoNTs) act on peripheral cholinergic nerve terminals, inducing reversible muscle paralysis and profound therapeutic effects. However, their limited cell-type specificity and narrow therapeutic window have motivated the development of engineered variants. Here, a modular strategy was employed to construct full-length chimeric BoNTs, grafting receptor-binding segments from BoNT/B or BoNT/F onto the BoNT/A framework. The novel chimeras AAAF and AAFF efficiently cleaved rSNAP-25 in cell-free assays. Firstly, both toxins showed effective cellular uptake and cleaved endogenous SNAP-25 in Neuro-2a cells, with cleavage efficiencies of approximately 46% for AAAF and 73% for AAFF, highlighting the enhanced activity of AAFF. Secondly, AAAF induced faster recovery from reversible muscle paralysis compared to rBoNT/A-WT, whereas AAFF produced more sustained paralysis, with both exhibiting reduced systemic toxicity. Despite these altered pharmacological profiles, the chimeras required higher doses than rBoNT/A-WT to induce neuromuscular effects. Collectively, this study presents the design of novel chimeric BoNT/A-F proteins, characterizes their functional activities, and provides a preliminary exploration of how domain grafting affects cellular uptake, enzymatic activity, and neuromuscular pharmacodynamics.
Open AccessDesign and Characterization of Recombinant and Chimeric BoNT/A Neurotoxins with Receptor-Binding Domain Grafting
Botulinum neurotoxins (BoNTs) act on peripheral cholinergic nerve terminals, inducing reversible muscle paralysis and profound therapeutic effects. However, their limited cell-type specificity and narrow therapeutic window have motivated the development of engineered variants. Here, a modular strategy was employed to construct full-length chimeric BoNTs, grafting receptor-binding segments from BoNT/B or BoNT/F onto the BoNT/A framework. The novel chimeras AAAF and AAFF efficiently cleaved rSNAP-25 in cell-free assays. Firstly, both toxins showed effective cellular uptake and cleaved endogenous SNAP-25 in Neuro-2a cells, with cleavage efficiencies of approximately 46% for AAAF and 73% for AAFF, highlighting the enhanced activity of AAFF. Secondly, AAAF induced faster recovery from reversible muscle paralysis compared to rBoNT/A-WT, whereas AAFF produced more sustained paralysis, with both exhibiting reduced systemic toxicity. Despite these altered pharmacological profiles, the chimeras required higher doses than rBoNT/A-WT to induce neuromuscular effects. Collectively, this study presents the design of novel chimeric BoNT/A-F proteins, characterizes their functional activities, and provides a preliminary exploration of how domain grafting affects cellular uptake, enzymatic activity, and neuromuscular pharmacodynamics.
- 6 February 2026
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 74 (6) , 5405-5416
De Novo Biosynthesis of Sabinene from Methanol by Multiple Engineered Pichia pastoris
Sabinene, a high-value monoterpene with broad industrial applications, is facing growing demand. To enable sustainable and cost-efficient production, we engineered the yeast Pichia pastoris for sabinene production from methanol. Through systematic metabolic engineering, we implemented a multipronged strategy to optimize sabinene biosynthesis: (1) enhancing precursor supply and synthase activity via fusion proteins (ERG20WW-tNPPS1 and ERG20WW-t37SabS1 (H561F)), (2) redirecting carbon flux through the phosphoketolase-phosphotransacetylase pathway, and (3) upregulating the mevalonate pathway via overexpression of a truncated HMGR. The engineered strain achieved record-high sabinene titers of 3.24 g/L in shake flasks and 6.38 g/L in a 3-L bioreactor. Notably, this yield surpasses those achieved with conventional sugar-based feedstocks in other microbial hosts, underscoring the potential of methanol as a superior carbon source for terpenoid biosynthesis. This work not only establishes P. pastoris as a promising platform for sabinene production, but also paves the way for methanol-based biomanufacturing of diverse natural products.
- 6 February 2026
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 74 (6) , 5405-5416
De Novo Biosynthesis of Sabinene from Methanol by Multiple Engineered Pichia pastoris
Sabinene, a high-value monoterpene with broad industrial applications, is facing growing demand. To enable sustainable and cost-efficient production, we engineered the yeast Pichia pastoris for sabinene production from methanol. Through systematic metabolic engineering, we implemented a multipronged strategy to optimize sabinene biosynthesis: (1) enhancing precursor supply and synthase activity via fusion proteins (ERG20WW-tNPPS1 and ERG20WW-t37SabS1 (H561F)), (2) redirecting carbon flux through the phosphoketolase-phosphotransacetylase pathway, and (3) upregulating the mevalonate pathway via overexpression of a truncated HMGR. The engineered strain achieved record-high sabinene titers of 3.24 g/L in shake flasks and 6.38 g/L in a 3-L bioreactor. Notably, this yield surpasses those achieved with conventional sugar-based feedstocks in other microbial hosts, underscoring the potential of methanol as a superior carbon source for terpenoid biosynthesis. This work not only establishes P. pastoris as a promising platform for sabinene production, but also paves the way for methanol-based biomanufacturing of diverse natural products.
- 17 July 2025
- Published by American Chemical Society (ACS) in ACS Synthetic Biology
- Vol. 14 (8) , 3127-3141
Engineering Temperature-Powered Synthetic Multilayer Molecular Bioswitch for High-Level Pyruvate Derivative Production in Escherichia coli
Microbial engineering and genetically encoded bioswitches provide an excellent platform for the production of high-value biochemicals. However, the synthesis of biobased compounds associated with central pathways or multiple bypasses is often restricted by robust central metabolism, incompatible metabolic homeostasis, and limited genetic tools. Here, a programmable and bifunctional temperature- and pyruvate-responsive biosensor was designed to establish an efficient biosynthesis platform for pyruvate derivatives. Especially, the novel variant L185P of regulator CI857 exhibited a 37.08% improvement in thermostability by forming a ring oscillation and a more rigid structure. Subsequently, the tool TPLC, based on thermosensor- and pyruvate biosensor-based layered circuit, was created. Using iso-butylamine synthesis as a proof-of-concept, a 3.31-fold increase in titer was achieved by precisely fine-tuning cell metabolism and bioproduct synthesis, and its titer further reached 46.24 g/L in a fermenter. This work highlights powerful toolkits for regulating multigene pathways, enabling the efficient production of high-value bioproducts of industrial interest of industry.
- 17 July 2025
- Published by American Chemical Society (ACS) in ACS Synthetic Biology
- Vol. 14 (8) , 3127-3141
Engineering Temperature-Powered Synthetic Multilayer Molecular Bioswitch for High-Level Pyruvate Derivative Production in Escherichia coli
Microbial engineering and genetically encoded bioswitches provide an excellent platform for the production of high-value biochemicals. However, the synthesis of biobased compounds associated with central pathways or multiple bypasses is often restricted by robust central metabolism, incompatible metabolic homeostasis, and limited genetic tools. Here, a programmable and bifunctional temperature- and pyruvate-responsive biosensor was designed to establish an efficient biosynthesis platform for pyruvate derivatives. Especially, the novel variant L185P of regulator CI857 exhibited a 37.08% improvement in thermostability by forming a ring oscillation and a more rigid structure. Subsequently, the tool TPLC, based on thermosensor- and pyruvate biosensor-based layered circuit, was created. Using iso-butylamine synthesis as a proof-of-concept, a 3.31-fold increase in titer was achieved by precisely fine-tuning cell metabolism and bioproduct synthesis, and its titer further reached 46.24 g/L in a fermenter. This work highlights powerful toolkits for regulating multigene pathways, enabling the efficient production of high-value bioproducts of industrial interest of industry.
- 22 May 2025
- Published by American Chemical Society (ACS) in ACS Synthetic Biology
- Vol. 14 (6) , 2341-2353
Metabolic Engineering of Clostridium tyrobutyricum for High-Yield n-Butanol Production by Increasing Intracellular Reducing Equivalent with NADPH-Dependent 3-Hydroxybutyryl-CoA Dehydrogenase
Clostridium tyrobutyricum was engineered to overexpress adhE2 encoding the aldehyde/alcohol dehydrogenase and an exogenous NADPH-dependent 3-hydroxybutyryl-CoA dehydrogenase from Clostridium kluyveri (Ckhbd) for n-butanol production. In general, large amounts of butyrate, acetate, and ethanol are also produced from glucose when butanol biosynthesis is hindered by limited intracellular NADH pools. In silico flux balance analysis showed that coupling NADP+/NADPH turnover with butanol production increased the reducing equivalent supply and butanol selectivity over ethanol and acids, thus increasing butanol production from glucose. This was verified with the coexpression of Ckhbd and adhE2 in C. tyrobutyricum wild type (WT), Ack, ΔhydA, and Δcat1 strains. Except for the Δcat1 strains, strains coexpressing Ckhbd showed significant (>5%) increase in reducing equivalents, 50-60% increase in butanol production (butanol yield: 0.24-0.28 vs. 0.15-0.18 g/g), and 2.5- to 4.5-fold increases in butanol/ethanol and alcohols/acids ratios due to increased flux from acetyl-CoA to butyryl-CoA and reducing equivalents compared to the strains expressing only adhE2. In the presence of methyl viologen, the strain Ack-adhE2-Ckhbd produced the highest butanol yield of 0.36 g/g, ∼88% of the theoretical yield from glucose, which was among the highest yields reported for known solventogenic clostridia.
- 22 May 2025
- Published by American Chemical Society (ACS) in ACS Synthetic Biology
- Vol. 14 (6) , 2341-2353
Metabolic Engineering of Clostridium tyrobutyricum for High-Yield n-Butanol Production by Increasing Intracellular Reducing Equivalent with NADPH-Dependent 3-Hydroxybutyryl-CoA Dehydrogenase
Clostridium tyrobutyricum was engineered to overexpress adhE2 encoding the aldehyde/alcohol dehydrogenase and an exogenous NADPH-dependent 3-hydroxybutyryl-CoA dehydrogenase from Clostridium kluyveri (Ckhbd) for n-butanol production. In general, large amounts of butyrate, acetate, and ethanol are also produced from glucose when butanol biosynthesis is hindered by limited intracellular NADH pools. In silico flux balance analysis showed that coupling NADP+/NADPH turnover with butanol production increased the reducing equivalent supply and butanol selectivity over ethanol and acids, thus increasing butanol production from glucose. This was verified with the coexpression of Ckhbd and adhE2 in C. tyrobutyricum wild type (WT), Ack, ΔhydA, and Δcat1 strains. Except for the Δcat1 strains, strains coexpressing Ckhbd showed significant (>5%) increase in reducing equivalents, 50-60% increase in butanol production (butanol yield: 0.24-0.28 vs. 0.15-0.18 g/g), and 2.5- to 4.5-fold increases in butanol/ethanol and alcohols/acids ratios due to increased flux from acetyl-CoA to butyryl-CoA and reducing equivalents compared to the strains expressing only adhE2. In the presence of methyl viologen, the strain Ack-adhE2-Ckhbd produced the highest butanol yield of 0.36 g/g, ∼88% of the theoretical yield from glucose, which was among the highest yields reported for known solventogenic clostridia.
- 20 April 2025
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 122 (7) , 1804-1815
Systems Metabolic Engineering of Clostridium tyrobutyricum for 1,3‐Propanediol Production From Crude Glycerol
Clostridium tyrobutyricum has emerged as a non‐pathogenic microbial cell factory capable of anaerobic production of various value‐added products, such as butyrate, butanol, and butyl butyrate. This study reports the first systematic engineering of C. tyrobutyricum for the heterologous production of 1,3‐propanediol (1,3‐PDO) from industrial by‐product crude glycerol. Initially, the glycerol reductive pathway for 1,3‐PDO production was constructed, and the unique glycerol oxidation pathway in C. tyrobutyricum was elucidated. Subsequently, the glycerol metabolism and 1,3‐PDO synthesis pathways were enhanced. Furthermore, the intracellular reducing power supply and the fermentation process were optimized to improve 1,3‐PDO production. Consequently, 54.06 g/L 1,3‐PDO with a yield of 0.64 mol/mol and a productivity of 1.13 g/L·h was obtained using crude glycerol and fish meal. The strategies described herein could facilitate the engineering of C. tyrobutyricum as a robust host for synthesizing valuable chemicals.
- 20 April 2025
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 122 (7) , 1804-1815
Systems Metabolic Engineering of Clostridium tyrobutyricum for 1,3‐Propanediol Production From Crude Glycerol
Clostridium tyrobutyricum has emerged as a non‐pathogenic microbial cell factory capable of anaerobic production of various value‐added products, such as butyrate, butanol, and butyl butyrate. This study reports the first systematic engineering of C. tyrobutyricum for the heterologous production of 1,3‐propanediol (1,3‐PDO) from industrial by‐product crude glycerol. Initially, the glycerol reductive pathway for 1,3‐PDO production was constructed, and the unique glycerol oxidation pathway in C. tyrobutyricum was elucidated. Subsequently, the glycerol metabolism and 1,3‐PDO synthesis pathways were enhanced. Furthermore, the intracellular reducing power supply and the fermentation process were optimized to improve 1,3‐PDO production. Consequently, 54.06 g/L 1,3‐PDO with a yield of 0.64 mol/mol and a productivity of 1.13 g/L·h was obtained using crude glycerol and fish meal. The strategies described herein could facilitate the engineering of C. tyrobutyricum as a robust host for synthesizing valuable chemicals.
- 22 March 2025
- Published by Elsevier in Bioresource Technology
- Vol. 427, 132438
Reprogramming Escherichia coli metabolism for butyrolactam production by the temperature-powered multi-genes control circuit
- 22 March 2025
- Published by Elsevier in Bioresource Technology
- Vol. 427, 132438
Reprogramming Escherichia coli metabolism for butyrolactam production by the temperature-powered multi-genes control circuit
- Open Access
- 1 January 2025
- Published by SCIE Publishing Limited in Synthetic Biology and Engineering
- Vol. 3 (2) , 10008
Quorum Sensing Systems Engineering for Enhanced iso-Butylamine Production in Escherichia coli
SCIEPublish is an international open-access journal publishing service provider run by SCIE Publishing Limited, dedicated to supporting and inspiring scientists or institutions/societies who aspire to publish high-quality journals.
- 1 January 2025
- Published by SCIE Publishing Limited in Synthetic Biology and Engineering
- Vol. 3 (2) , 10008
Open AccessQuorum Sensing Systems Engineering for Enhanced iso-Butylamine Production in Escherichia coli
SCIEPublish is an international open-access journal publishing service provider run by SCIE Publishing Limited, dedicated to supporting and inspiring scientists or institutions/societies who aspire to publish high-quality journals.